WAIfinder: a new digital tool to maximise connectivity across the UK AI landscape 

UKRI has launched WAIfinder, an online tool to showcase AI capability in the UK and to increase connections across the UK Artificial Intelligence R&D ecosystem.

In order to to make navigating the UK’s artificial intelligence R & D ecosystem easier, UK Research and Innovation (UKRI) has launched “WAIFinder”, a new interactive digital map.  

The new interactive digital map, WAIFinder has been developed for social good to support ecosystem facilitation and maximise connectivity across the AI landscape. It will allow researchers and innovators to browse companies, funders, incubators and academic institutions that are involved in creating artificial intelligence (AI) products, services, processes and research. 

Users will be able to browse companies, research institutions, funders and incubators that are involved in creating and funding AI products, services, processes and research. The tool will make it easier to find information and navigate the UK’s dynamic AI R&D landscape as well as find partners to collaborate with. 

WAIFinder is web-based and is dynamic and updated constantly. It is freely accessible to users. 

***

References:  

  1. UKRI 2024. News – New tool launched to navigate the UK’s world-leading AI landscape. Posted 19 February 2024. Available at https://www.ukri.org/news/new-tool-launched-to-navigate-the-uks-world-leading-ai-landscape/?utm_medium=email&utm_source=govdelivery  
  1. UK WAIfinder. https://waifinder.iuk.ktn-uk.org/  

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Anti-Malaria Vaccines: Will New Found DNA Vaccine Technology Influence Future Course?

Developing vaccine against malaria has been among the biggest...

Dentistry: Povidone Iodine (PVP-I) Prevents and Treats Early Phases of COVID-19

Povidone Iodine (PVP-I) can be used in the form...

The Paralyzed Arms and Hands Restored by Nerve Transfer

Early nerve transfer surgery to treat paralysis of arms...

Low EROI of Fossil Fuels: Case for Developing Renewable Sources

Study has calculated energy-return-on-investment (EROI) ratios for fossil fuels...

Consumption of Highly Processed Foods and Health: New Evidences from Research

Two studies provide evidences that associate high consumption of...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.